China Pharma Holdings (CPHI) Leases (2018 - 2025)
Historic Leases for China Pharma Holdings (CPHI) over the last 8 years, with Q3 2025 value amounting to $197851.0.
- China Pharma Holdings' Leases rose 23573.33% to $197851.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $197851.0, marking a year-over-year increase of 23573.33%. This contributed to the annual value of $38298.0 for FY2024, which is 6715.72% down from last year.
- Per China Pharma Holdings' latest filing, its Leases stood at $197851.0 for Q3 2025, which was up 23573.33% from $19176.0 recorded in Q1 2025.
- Over the past 5 years, China Pharma Holdings' Leases peaked at $197851.0 during Q3 2025, and registered a low of $19176.0 during Q1 2025.
- Moreover, its 5-year median value for Leases was $89022.5 (2022), whereas its average is $92558.3.
- As far as peak fluctuations go, China Pharma Holdings' Leases plummeted by 8152.37% in 2023, and later surged by 39025.12% in 2024.
- Quarter analysis of 5 years shows China Pharma Holdings' Leases stood at $127958.0 in 2021, then plummeted by 69.49% to $39046.0 in 2022, then surged by 198.65% to $116610.0 in 2023, then tumbled by 67.16% to $38298.0 in 2024, then skyrocketed by 416.61% to $197851.0 in 2025.
- Its Leases was $197851.0 in Q3 2025, compared to $19176.0 in Q1 2025 and $38298.0 in Q4 2024.